Browse EX-10 agreements

Execution Version

Lake Street Capital Markets, LLC
121 South 8th Street, Suite 1000
Minneapolis, Minnesota 55402

Laidlaw & Company (UK) Ltd.
521 Fifth Avenue, 12th Floor
New York, NY 10175

July 13, 2026

Private and Confidential

AEON Biopharma, Inc.

5 Park Plaza

Suite 1750

Irvine, CA 92614

Attention:Robert Bancroft

President and Chief Executive Officer

Dear Robert:

We understand that AEON Biopharma, Inc., a Delaware corporation (the “Company”), has requested that Lake Street Capital Markets, LLC and Laidlaw & Company (UK) Ltd. (collectively, the “Agents”) act as the Company’s solicitation agents in connection with the exercise of the Common Warrants (as defined in the Underwriting Agreement) and the Option Common Warrants (as defined in the Underwriting Agreement) (the Common Warrants and the Option Common Warrants together, the “Milestone Warrants”) to be issued pursuant to that certain Underwriting Agreement, dated as of the date hereof (the “Underwriting Agreement”), between the Company and Lake Street Capital Markets, LLC, as representative of the several under

…

This agreement has been filed to provide investors with information regarding its terms. It is not intended to provide any other factual information about the Tennessee Valley Authority. The representations and warranties of the parties in this agreement were made to, and solely for the benefit of, the other parties to this agreement. The assertions embodied in the representations and warranties may be qualified by information included in schedules, exhibits, or other materials exchanged by the parties that modify or create exceptions to the representations and warranties. Accordingly, investors should not rely on the representations and warranties as characterizations of the actual state of facts at the time they were made or otherwise.

EXECUTION VERSION

THIRD AMENDED AND RESTATED JULY MATURITY CREDIT AGREEMENT

Dated as of July 10, 2026

Among

TENNESSEE VALLEY AUTHORITY,

as the Borrower

TORONTO DOMINION (TEXAS) LLC,

as Administrative Agent

THE TORONTO-DOMINION BANK, NEW YORK BRANCH,

as a Lender and L/C Issuer

and

THE OTHER LENDERS PARTY HERETO

Arranged By:

…

**AMENDMENT **

**TO **

LINE OF CREDIT AGREEMENT

THIS AMENDMENT TO THE LINE OF CREDIT AGREEMENT (this “Amendment”), dated as of July 13, 2026, is made by and among NextTrip, Inc, a Nevada corporation (the “Borrower”), and Monaco Investment Partners II, LP, a Limited Partnership organized under the laws of the State of Illinois (the “Lender”). The Borrower and Lender shall be referred to herein, jointly, as the “Parties” and, individually, as a “Party.”

RECITALS

WHEREAS, the Borrower and the Lender entered into that certain Line of Credit Agreement, dated as of May 6, 2025 (as may be amended, restated, supplemented and otherwise modified from time to time, the “Credit Agreement”);

WHEREAS, the original maturity date for the Credit Agreement was May 31, 2027 (the “Original Maturity Date”);

WHEREAS, pursuant to Section 6.2 of the Credit Agreement, a written instrument executed by the Borrower and the Lender is required to amend the Credit Agreement; and

…

…

PROMISSORY NOTE

Borrower:	First Mid Bancshares, Inc.		Lender:	Bankers' Bank
	1421 Charleston Avenue			7700 Mineral Point Road
	Mattoon, IL 61938			Madison, WI 53717

Principal Amount: $19,709,626.03		Date of Note: July 10, 2026

…

THIRD AMENDMENT TO TERM LOAN AND
SECURITY AGREEMENT

THIRD AMENDMENT TO TERM LOAN AND SECURITY AGREEMENT, dated as of July 13, 2026 (this “Third Amendment”), among GENASYS INC., a Delaware corporation (“Borrower”), the Guarantors party hereto, the Lenders party hereto and CANTOR FITZGERALD SECURITIES, in its capacities as Administrative Agent and Collateral Agent (collectively, the “Agent”).

WHEREAS, Borrower, the Guarantors, the Lenders and Agent entered into the Term Loan and Security Agreement, dated as of May 13, 2024 (as amended, restated other otherwise modified prior to the date hereof, the “Existing Loan Agreement”); and

WHEREAS, Borrower, Guarantors, Lenders and Agent have agreed to amend the Existing Loan Agreement to, among other things, extend the Maturity Date of the Closing Date Term Loan under the Existing Loan Agreement.

NOW, THEREFORE, the parties hereto agree as follows:

ARTICLE I.

DEFINITIONS AND RULES OF CONSTRUCTION

Section 1.1

…

FIRST AMENDMENT

TO

WARRANT AGREEMENT

This First Amendment (this “Amendment”) to that certain Warrant Agreement dated as of dated as of May 13, 2024, by and between Genasys Inc., a Delaware corporation, (the “Company”) and Issuer Direct Corporation as warrant agent (together with its successors and assigns, the “Warrant Agent”) (the “Warrant Agreement”) is entered into as of July 13, 2026, 2026 by and between the Company, the Warrant Agent and the undersigned Holders (as defined in the Warrant Agreement)

WHEREAS, pursuant to Section 8.5 of the Warrant Agreement, the Warrant Agreement may be amended, modified or waived pursuant to a written agreement signed by the Warrant Agent and the Company and consented to by the Super-Majority Holders;

WHEREAS, the undersigned Holders constitute the Super-Majority Holders; and

WHEREAS, Company, the Warrant Agent and the undersigned Holders desire to amend certain provisions of the Warrant Agreement, as set forth in greater detail and subject to the terms and conditions outlined in this Amendment.

…

CONTINGENT VALUE RIGHTS AGREEMENT

This CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [•], 2026 (this “Agreement”), is entered into by and among Senti Holdings, Inc., a Delaware corporation (“Midco”), and [•] (as the “Rights Agent” (as hereinafter defined)).

RECITALS

WHEREAS, this Agreement is entered into pursuant to the Agreement and Plan of Merger (the “Merger Agreement”), dated as of July [•], 2026, by and among Celadon Partners SPV 35, an exempted company incorporated under the laws of the Cayman Islands, Senti Merger Sub, Inc., a Delaware corporation (“Merger Sub”), Senti Biosciences Holdings, Inc., a Delaware corporation (the “Company”), Midco, and Senti Biosciences, Inc., a Delaware corporation (the “Opco”), pursuant to which Merger Sub will be merged with and into Midco (the “Merger”), with Midco continuing as the surviving corporation in the Merger (the “Surviving Corporation”), on the terms and subject to the conditions set forth in the Merger Agreement; and

…

EMPLOYMENT AGREEMENT

THIS EMPLOYMENT AGREEMENT (this “Agreement”), dated as of this ______ day of July, 2026, is made by and between Hycroft Mining Holding Corporation, a Delaware corporation (the “Company”) and Michael J. Deal (the “Employee”).

**WHEREAS, **the Company desires to employ the Employee in the capacity Senior Vice President, Chief Operating Officer (SVP, COO); and

WHEREAS, the Company and the Employee have reached agreement concerning the terms and conditions of his employment and wish to formalize that agreement.

NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth in this Agreement, the Company and the Employee agree as follows:

…

GOSSAMER BIO, INC. 2019 INCENTIVE AWARD PLAN (As Amended and Restated Effective May 18, 2026) ARTICLE I. PURPOSE The purpose of this amended and restated Plan is to enhance the Company’s ability to attract, retain and motivate persons who make (or are expected to make) important contributions to the Company by providing these individuals with equity ownership opportunities. Capitalized terms used in the Plan are defined in Article XI. This Plan constitutes an amendment and restatement of the Gossamer Bio, Inc. 2019 Incentive Award Plan (the “Existing Plan”), effective as of the Restatement Effective Date (as defined below). The Plan was first adopted by the Board on January 12, 2019, and approved by the stockholders of the Company on January 15, 2019, and effective on February 7, 2019 (the “Original Effective Date”), and was most recently amended and restated by the Board on March 24, 2025 and approved by the stockholders of the Company on June 25, 2025. ARTICLE II. ELIGIBILITY Service Providers are eligible to be granted Awards under the Plan, subject to the limitations described he

…

T. ROWE PRICE ACTIVE CRYPTO ETF 8-K

Exhibit 10.1

FORM OF DIGITAL ASSET TRADING AGREEMENT

DIGITAL ASSET TRADING AGREEMENT

This DIGITAL ASSET TRADING AGREEMENT (including all terms, schedules, annexes, supplements and exhibits attached hereto, this “Agreement”), is made and entered into on this 12th day of June, 2026, by and between StoneX Digital LLC, a Florida limited liability company (“StoneX”), and T. Rowe Price Sponsor LLC, acting solely as agent on behalf of Counterparty specified on the signature page hereof (“Counterparty”, and together with StoneX, the “Parties” and each a “Party”).

WHEREAS, the Parties desire to enter into periodic transactions for the purchase and sale of cryptocurrency in accordance with the terms and conditions as set forth herein.

NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

Article I.
PURCHASE AND SALE OF CRYPTOCURRENCY

…

T. ROWE PRICE ACTIVE CRYPTO ETF 8-K

Exhibit 10.2

LIQUIDITY PROVIDER AGREEMENT

FOR TRADING IN DIGITAL ASSETS

** **

This LIQUIDITY PROVIDER AGREEMENT FOR TRADING IN DIGITAL ASSETS (this “Agreement”), is made and entered into as of this 15 day of May, 2026, by and between Virtu Financial Singapore Pte. Ltd., (“Liquidity Provider”) and T. Rowe Price Sponsor LLC, (“Sponsor”), acting as agent and not in its individual capacity, on behalf of the Fund (“Counterparty”). Liquidity Provider and Counterparty are each a “Party”, and collectively, the “Parties”.

WHEREAS, the Parties desire to enter into spot purchase or sale transactions in digital assets on a principal to principal basis (each such trade, a “Transaction”);

NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

ARTICLE I.

SALE AND PURCHASE OF DIGITAL ASSETS

…